H. Trypanosomiasis and . African, Sleeping Sickness)/Fact Sheets, p.28, 2018.

A. Kryshchyshyn, D. Kaminskyy, P. Grellier, and R. Lesyk, Trends in research of antitrypanosomal agents among synthetic heterocycles, Eur. J. Med. Chem, vol.85, pp.51-64, 2014.
URL : https://hal.archives-ouvertes.fr/mnhn-02047351

S. Parveen, M. O. Khan, S. E. Austin, S. L. Croft, V. Yardley et al., Antitrypanosomal, antileishmanial, and antimalarial activities of quaternary arylalkylammonium 2-amino-4-chlorophenyl phenyl sulfides, a new class of trypanothione reductase inhibitor, and of N-acyl derivatives of 2-amino-4-chlorophenyl phenyl sulfide, J. Med. Chem, vol.48, pp.8087-8097, 2005.

S. A. Bakunov, S. M. Bakunova, T. Wenzler, M. Ghebru, K. A. Werbovetz et al., Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles, J. Med. Chem, vol.53, pp.254-272, 2009.

I. H. Gilbert, Inhibitors of dihydrofolate reductase in Leishmania and trypanosomes, Biochim. Biophys. Acta, vol.1587, pp.249-257, 2002.

A. L. Bodley and T. A. Shapiro, Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania, Proc. Natl. Acad. Sci, vol.92, pp.3726-3730, 1995.

, Sci. Pharm, vol.86, p.10, 2018.

R. B. Lesyk, B. S. Zimenkovsky, D. V. Kaminskyy, A. P. Kryshchyshyn, D. Y. Havrylyuk et al., Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group, Biopolym. Cell, vol.27, pp.107-117, 2011.

D. Kaminskyy, A. Kryshchyshyn, and R. Lesyk, Recent developments with rhodanine as a scaffold for drug discovery, Expert Opin. Drug Discov, vol.12, pp.1233-1252, 2017.

D. Kaminskyy, A. Kryshchyshyn, and R. Lesyk, 5-Ene-4-thiazolidinones-An efficient tool in medicinal chemistry, Eur. J. Med. Chem, vol.140, pp.542-594, 2017.

T. Toma?i´ctoma?i´c and L. ;-peterlin-ma?i?, Rhodanine as a scaffold in drug discovery: A critical review of its biological activities and mechanisms of target modulation, Expert Opin. Drug Discov, vol.7, pp.549-560, 2012.

V. S. Jain, D. K. Vora, and C. S. Ramaa, Thiazolidine-2,4-diones: Progress towards multifarious applications, Bioorg. Med. Chem, vol.21, pp.1599-1620, 2013.

M. A. Metwally, A. A. Farahat, and B. F. Abdel-wahab, 2-Amino-4-thiazolidinones: Synthesis and reactions, J. Sulfur Chem, pp.315-349, 2010.

P. A. Gomes, A. R. Oliveira, M. V. Cardoso, E. F. Santiago, M. O. Barbosa et al., Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi, Eur. J. Med. Chem, vol.111, pp.46-57, 2016.

D. R. Magalhaes-moreira, A. D. Oliveira, . Teixeira-de-moraes, P. A. Gomes, C. A. De-simone et al., Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death, Eur. J. Med. Chem, vol.75, pp.467-478, 2014.

J. W. Espíndola, M. V. Cardoso, G. B. Filho, . Oliveira, D. A. Silva et al., Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain, Eur. J. Med. Chem, vol.101, pp.818-835, 2015.

G. Aguirre, L. Boiani, H. Cerecetto, M. Fernández, M. González et al., In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones, Bioorg. Med. Chem, vol.12, pp.4885-4893, 2004.

M. V. Cardoso, L. R. De-siqueira, E. B. Silva, L. B. Costa, M. Z. Hernandes et al., 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: Structural design, synthesis and pharmacological evaluation, Eur. J. Med. Chem, vol.86, pp.48-59, 2014.

A. C. Leite, R. S. De-lima, D. R. Moreira, M. V. Cardoso, A. C. Gouveia-de-brito et al., Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acylthiazolidones against Trypanosoma cruzi, Bioorg. Med. Chem, vol.14, pp.3749-3757, 2006.

A. C. Leite, D. R. Moreira, M. V. Cardoso, M. Z. Hernandes, V. R. Pereira et al., Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi, ChemMedChem, vol.2, pp.1339-1345, 2007.

M. Z. Hernandes, M. M. Rabello, A. C. Leite, M. V. Cardoso, D. R. Moreira et al., Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents, Bioorg. Med. Chem, vol.18, pp.7826-7835, 2010.

R. M. Moreira, M. Z. Hernandes, M. M. Rabello, L. F. Da-cruz, R. S. Ferreira et al., Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity, ChemMedChem, vol.9, pp.177-188, 2014.

G. B. De-oliveira-filho, M. V. De-oliveira-cardoso, J. W. Espíndola, L. F. Ferreira, C. A. De-simone et al., Structural design, synthesis and pharmacological evaluation of 4-thiazolidinones against Trypanosoma cruzi, Bioorg. Med. Chem, vol.23, pp.7478-7486, 2015.

, Sci. Pharm, vol.86, p.10, 2018.

D. Havrylyuk, B. Zimenkovsky, O. Vasylenko, C. W. Day, D. F. Smee et al., Synthesis and biological activity evaluation of 5-pyrazoline substituted 4-thiazolidinones, Eur. J. Med. Chem, vol.66, pp.228-237, 2013.
URL : https://hal.archives-ouvertes.fr/mnhn-02047380

D. Havrylyuk, B. Zimenkovsky, O. Karpenko, P. Grellier, and R. Lesyk, Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity, Eur. J. Med. Chem, vol.85, pp.245-254, 2014.
URL : https://hal.archives-ouvertes.fr/mnhn-02047347

D. Kaminskyy, A. Kryshchyshyn, I. Nektegayev, O. Vasylenko, P. Grellier et al., Isothiocoumarin-3-carboxylic acid derivatives: Synthesis, anticancer and antitrypanosomal activity evaluation, Eur. J. Med. Chem, vol.75, pp.57-66, 2014.
URL : https://hal.archives-ouvertes.fr/mnhn-02070057

J. B. Baell and J. W. Nissink, Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017-Utility and Limitations, ACS Chem. Biol, vol.13, pp.36-44, 2017.

A. Kryshchyshyn, B. Zimenkovsky, and R. Lesyk, Synthesis and anticancer activity of isothiochromeno[3,4-d]thiazole derivatives. Ann. Univ. Mar. Curie Sklodowska DDD Pharm, vol.21, pp.247-251, 2008.

A. Kryshchyshyn, D. Atamanyuk, and R. Lesyk, Fused thiopyrano[2,3-d]thiazole derivatives as potential anticancer agents, Sci. Pharm, vol.80, pp.509-529, 2012.

A. P. Kryshchyshyn, D. V. Atamanyuk, D. V. Kaminskyy, P. Grellier, and R. B. Lesyk, Investigation of anticancer and anti-parasitic activity of thiopyrano[2,3-d]thiazoles bearing norbornane moiety, Biopolym. Cell, vol.33, pp.183-205, 2017.

A. Kryshchyshyn, O. Roman, A. Lozynskyi, R. Lesyk, and . Thiopyrano, 3-d]thiazoles as New Efficient Scaffolds in Medicinal Chemistry, Sci. Pharm, vol.2, 2018.

D. Steverding and X. Wang, Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib, Parasit. Vectors, vol.2, p.29, 2009.

A. Deterding, F. Dungey, K. Thompson, and D. Steverding, Anti-trypanosomal activities of DNA topoisomerase inhibitors, Acta Trop, vol.93, pp.311-316, 2005.

V. Matiychuk, R. Lesyk, M. Obushak, A. Gzella, D. Atamanyuk et al., A new domino-Knoevenagel-hetero-Diels-Alder reaction, Tetrahedron Lett, vol.49, pp.4648-4651, 2008.

W. G. Smith, 1 Pharmacological Screening Tests, Prog. Med. Chem, vol.1, pp.1-33, 1961.

S. Lethu, D. Bosc, E. Mouray, P. Grellier, and J. Dubois, New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: Diversification of the aryl moiety by solid-phase synthesis, J. Enzym. Inhib. Med. Chem, vol.1, pp.163-171, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00798409

F. Pérez-cruz, S. Serra, G. Delogu, M. Lapier, J. Diego-maya et al., Antitrypanosomal and antioxidant properties of 4-hydroxycoumarins derivatives, Bioorg. Med. Chem. Lett, vol.22, pp.5569-5573, 2012.

J. T. Litchfield and F. Wilcoxon, A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther, vol.96, pp.99-113, 1949.

A. Kryshchychyn and R. Lesyk, Synthesis and antitumor activity study of new isothiochromeno, Pharm. Rev, vol.2, pp.6-10, 2010.